Suppr超能文献

相似文献

1
Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model.
Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11159-64. doi: 10.1073/pnas.0402026101. Epub 2004 Jul 19.
2
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).
Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1604-9. doi: 10.1073/pnas.032539299. Epub 2002 Jan 29.
5
Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Toxicology. 2013 Sep 6;311(1-2):69-77. doi: 10.1016/j.tox.2013.04.004. Epub 2013 Apr 11.
7
The metabolic hypothesis in amyotrophic lateral sclerosis: insights from mutant Cu/Zn-superoxide dismutase mice.
Biomed Pharmacother. 2005 May;59(4):190-6. doi: 10.1016/j.biopha.2005.03.003. Epub 2005 Mar 17.
8
Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.
Neurodegener Dis. 2004;1(6):245-54. doi: 10.1159/000085063.
9
Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Neurobiol Dis. 2007 Nov;28(2):154-64. doi: 10.1016/j.nbd.2007.07.003. Epub 2007 Jul 10.

引用本文的文献

1
The myokine FGF21 associates with enhanced survival in ALS and mitigates stress-induced cytotoxicity.
Aging (Albany NY). 2025 Aug 9;17(8):2033-2062. doi: 10.18632/aging.206298.
2
Unlocking amyotrophic lateral sclerosis: the role of adiponectin in inflammation and disease progression.
Front Neurol. 2025 Jul 4;16:1605822. doi: 10.3389/fneur.2025.1605822. eCollection 2025.
4
Environmental risk factors, protective factors, and biomarkers for amyotrophic lateral sclerosis: an umbrella review.
Front Aging Neurosci. 2025 Jun 13;17:1541779. doi: 10.3389/fnagi.2025.1541779. eCollection 2025.
5
Neural Metabolic Networks: Key Elements of Healthy Brain Function.
J Neurochem. 2025 Jun;169(6):e70084. doi: 10.1111/jnc.70084.
7
Gene therapy breakthroughs in ALS: a beacon of hope for 20% of ALS patients.
Transl Neurodegener. 2025 Apr 16;14(1):19. doi: 10.1186/s40035-025-00477-6.
10
An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosis.
Brain Commun. 2025 Feb 8;7(1):fcaf063. doi: 10.1093/braincomms/fcaf063. eCollection 2025.

本文引用的文献

1
Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice.
Science. 2003 Oct 3;302(5642):113-7. doi: 10.1126/science.1086071.
3
A randomized sequential trial of creatine in amyotrophic lateral sclerosis.
Ann Neurol. 2003 Apr;53(4):437-45. doi: 10.1002/ana.10554.
4
SRC-1 and TIF2 control energy balance between white and brown adipose tissues.
Cell. 2002 Dec 27;111(7):931-41. doi: 10.1016/s0092-8674(02)01169-8.
5
Nutritional issues and supplements in amyotrophic lateral sclerosis and other neurodegenerative disorders.
Curr Opin Clin Nutr Metab Care. 2002 Nov;5(6):631-43. doi: 10.1097/00075197-200211000-00005.
6
Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis.
Neurobiol Dis. 2002 Aug;10(3):358-65. doi: 10.1006/nbdi.2002.0522.
7
Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease.
J Neurosci. 2002 Jun 15;22(12):4825-32. doi: 10.1523/JNEUROSCI.22-12-04825.2002.
8
Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice.
J Biol Chem. 2002 Aug 16;277(33):29626-33. doi: 10.1074/jbc.M203065200. Epub 2002 Jun 5.
10
Mitochondrial involvement in amyotrophic lateral sclerosis.
Neurochem Int. 2002 May;40(6):543-51. doi: 10.1016/s0197-0186(01)00125-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验